JCN Newswire | Asia Press Release Distribution

OBI-902、米国FDAより胆管癌治療を対象とした希少疾病用医薬品指定を取得 Nov 17, 2025 23:00 JST
Destinator Earns the Highest Rating of Five Stars in 2025 ASEAN NCAP Nov 17, 2025 22:32 JST
"LEQEMBI(R)" (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Approved in the United Kingdom Nov 17, 2025 22:08 JST
OBI-902 has been granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma Nov 17, 2025 21:00 JST
NEC Advances Research Information Infrastructure for Open Science Nov 17, 2025 21:38 JST
Mitsubishi Shipbuilding Delivers Large Car Ferry KEYAKI to Shin Nihonkai Ferry and Japan Railway Construction, Transport and Technology Agency Nov 17, 2025 21:00 JST
富士通、Business Creation LabでAWSジャパンと流通・サービス業界の未来を変革、生成AIで加速 Nov 17, 2025 12:00 JST
Hitachi Employee Receives the "Chop Wood Carry Water Award" from the Global OSS Organization CNCF for Leading the Establishment of Official Community in Japan Nov 14, 2025 21:06 JST
Chuangxin Industries Holdings Limited, a Green Electrolytic Aluminum and Alumina Producer, Announces its Plan to List on the Main Board of the Hong Kong Stock Exchange Nov 14, 2025 14:14 JST
アリックスパートナーズ、世界のEVバッテリー業界レポートを発表 Nov 14, 2025 11:00 JST
More Press Releases >>

JBM Healthcare Announces FY2026 Interim Results Nov 17, 2025 22:43 JST
健倍苗苗公佈二零二六財政年度中期業績 Nov 17, 2025 22:43 JST
健倍苗苗公布二零二六财政年度中期业绩 Nov 17, 2025 22:43 JST
OBI-902 獲美國 FDA 審核通過治療膽管癌的「孤兒藥」資格認定 Nov 17, 2025 21:00 JST
OBI-902获美国FDA审核通过用于治疗胆管癌的“孤儿药”资格认定 Nov 17, 2025 21:00 JST
More Press Releases >>